Delivery Order SPE2DB24D2010-SPE2DB25FZVR7

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,779.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for 4,566,307,494 units of isotretinoin 30 mg capsules, with a completion date of November 4, 2024. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,304.77 firm fixed-price delivery order is for the supply of ISOTRETINOIN 30 MG CAPSULE 30S, a generic pharmaceutical product. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of isotretinoin 30 mg capsules. The $3,011.85 firm fixed-price delivery order has an ultimate completion date of December 13, 2024. There was no set-aside designation for this open competition award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $1,503.54, is a Delivery Order for the supply of 4566251129 ISOTRETINOIN 30 MG CAPSULE 30S. The contract has an ultimate completion date of October 29, 2024 and a pricing type of Firm Fixed Price. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,393.79, is for the delivery of 4563653620 - Isotretinoin 30 mg Capsule 30s, a pharmaceutical product. The contract has a completion date of February 14, 2024 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside designation. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,434.82 firm fixed-price delivery order is for the supply of ISOTRETINOIN 30 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,327.27, is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of 4,566,629,122 units of the medication isotretinoin 30 mg capsules. The $4,723.68 firm fixed-price delivery order has a completion date of December 6, 2024 and was awarded on December 5, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a $15,376.57 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply isotretinoin 30 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. Amerisourcebergen, through its...
This federal contract award is a Delivery Order valued at $2,535.67, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566373861 Isotretinoin 30 mg capsules, with a completion date of November 8, 2024. The contract type is Firm Fixed Price, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZVR7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,291.94 firm fixed-price delivery order is for the supply of 4567359979 Isotretinoin 30 mg capsules, with a completion date of February 25, 2025.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This order appears to be part of that larger IDC contract, which covers critical medical commodities across multiple therapeutic areas. The contract award did not have a set-aside designation, indicating open competition.

Generated 6/1/25, 2:48 AM